메뉴 건너뛰기




Volumn 15, Issue 1, 2014, Pages 38-51

Prevention and treatment of no-reflow phenomenon by targeting the coronary microcirculation

Author keywords

Coronary microcirculation; Microvascular obstruction; No reflow

Indexed keywords

ANTITHROMBOCYTIC AGENT; VASODILATOR AGENT;

EID: 84901943862     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: 10.3909/ricm0699     Document Type: Review
Times cited : (23)

References (90)
  • 1
    • 77952127532 scopus 로고    scopus 로고
    • 5-Year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction
    • Ndrepepa G, Tiroch K, Fusaro M, et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol. 2010;55:2383-2389.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 2383-2389
    • Ndrepepa, G.1    Tiroch, K.2    Fusaro, M.3
  • 2
    • 78650149037 scopus 로고    scopus 로고
    • Angiographic assessment of microvascular perfusion-myocardial blush in clinical practice
    • Porto I, Hamilton-Craig C, Brancati M, et al. Angiographic assessment of microvascular perfusion-myocardial blush in clinical practice. Am Heart J. 2010;160:1015-1022.
    • (2010) Am Heart J , vol.160 , pp. 1015-1022
    • Porto, I.1    Hamilton-Craig, C.2    Brancati, M.3
  • 3
    • 33747874714 scopus 로고    scopus 로고
    • No-reflow phenomenon and prognosis in patients with acute myocardial infarction
    • DOI 10.1038/ncpcardio0632, PII NCPCARDIO0632
    • Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med. 2006;3:499-506. (Pubitemid 44288463)
    • (2006) Nature Clinical Practice Cardiovascular Medicine , vol.3 , Issue.9 , pp. 499-506
    • Ito, H.1
  • 4
    • 84872028243 scopus 로고    scopus 로고
    • Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction
    • American College of Cardiology National Cardiovascular Data Registry
    • Harrison RW, Aggarwal A, Ou FS, et al American College of Cardiology National Cardiovascular Data Registry. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol. 2013;111:178-184.
    • (2013) Am J Cardiol , vol.111 , pp. 178-184
    • Harrison, R.W.1    Aggarwal, A.2    Ou, F.S.3
  • 5
    • 0016315064 scopus 로고
    • The "no-reflow" phenomenon after temporary coronary occlusion in the dog
    • Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496-1508.
    • (1974) J Clin Invest , vol.54 , pp. 1496-1508
    • Kloner, R.A.1    Ganote, C.E.2    Jennings, R.B.3
  • 6
    • 0019143016 scopus 로고
    • Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: Which comes first?
    • Kloner RA, Rude RE, Carlson N, et al. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation. 1980;62:945-952. (Pubitemid 11225959)
    • (1980) Circulation , vol.62 , Issue.5 , pp. 945-952
    • Kloner, R.A.1    Rude, R.E.2    Carlson, N.3
  • 7
    • 80051474178 scopus 로고    scopus 로고
    • Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction
    • Kobatake R, Sato T, Fujiwara Y, et al. Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction. Heart Vessels. 2011;26:379-384.
    • (2011) Heart Vessels , vol.26 , pp. 379-384
    • Kobatake, R.1    Sato, T.2    Fujiwara, Y.3
  • 8
    • 77957742916 scopus 로고    scopus 로고
    • No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: Incidence, outcome, and effect of pharmacologic therapy
    • Rezkalla SH, Dharmashankar KC, Abdalrahman IB, Kloner RA. No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. J Interv Cardiol. 2010;23:429-436.
    • (2010) J Interv Cardiol , vol.23 , pp. 429-436
    • Rezkalla, S.H.1    Dharmashankar, K.C.2    Abdalrahman, I.B.3    Kloner, R.A.4
  • 9
    • 33847231568 scopus 로고    scopus 로고
    • Coronary microvascular dysfunction
    • Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830-840.
    • (2007) N Engl J Med , vol.356 , pp. 830-840
    • Camici, P.G.1    Crea, F.2
  • 10
    • 0016698772 scopus 로고
    • Reduced myocardial reflow and increased coronary vascular resistance following prolonged myocardial ischemia in the dog
    • Willerson JT, Watson JT, Hutton I, et al. Reduced myocardial reflow and increased coronary vascular resistance following prolonged myocardial ischemia in the dog. Circ Res. 1975;36:771-781.
    • (1975) Circ Res , vol.36 , pp. 771-781
    • Willerson, J.T.1    Watson, J.T.2    Hutton, I.3
  • 11
    • 0020676313 scopus 로고
    • Coronary physiology
    • Feigl EO. Coronary physiology. Physiol Rev. 1983;63:1-205. (Pubitemid 13188482)
    • (1983) Physiological Reviews , vol.63 , Issue.1 , pp. 1-205
    • Feigl, E.O.1
  • 12
    • 0025047567 scopus 로고
    • Endothelium-dependent, flow-induced dilation of isolated coronary arterioles
    • Kuo L, Davis MJ, Chilian WM. Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol. 1990;259(4 Pt 2):H1063-H1070.
    • (1990) Am J Physiol , vol.259 , Issue.4 PART 2
    • Kuo, L.1    Davis, M.J.2    Chilian, W.M.3
  • 13
    • 54149110403 scopus 로고    scopus 로고
    • A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings
    • Pries AR, Habazettl H, Ambrosio G, et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovasc Res. 2008;80:165-174.
    • (2008) Cardiovasc Res , vol.80 , pp. 165-174
    • Pries, A.R.1    Habazettl, H.2    Ambrosio, G.3
  • 14
    • 33746399281 scopus 로고    scopus 로고
    • Non-invasive coronary flow reserve is correlated with microvascular integrity and myocardial viability after primary angioplasty in acute myocardial infarction
    • DOI 10.1136/hrt.2005.078246
    • Montisci R, Chen L, Ruscazio M, et al. Non-invasive coronary flow reserve is correlated with microvascular integrity and myocardial viability after primary angioplasty in acute myocardial infarction. Heart. 2006;92:1113-1118. (Pubitemid 44125232)
    • (2006) Heart , vol.92 , Issue.8 , pp. 1113-1118
    • Montisci, R.1    Chen, L.2    Ruscazio, M.3    Colonna, P.4    Cadeddu, C.5    Caiati, C.6    Montisci, M.7    Meloni, L.8    Iliceto, S.9
  • 15
    • 0030728423 scopus 로고    scopus 로고
    • Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects
    • Hasdai D, Gibbons RJ, Holmes DR Jr, et al. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation. 1997;96:3390-3395. (Pubitemid 27513410)
    • (1997) Circulation , vol.96 , Issue.10 , pp. 3390-3395
    • Hasdai, D.1    Gibbons, R.J.2    Holmes Jr., D.R.3    Higano, S.T.4    Lerman, A.5
  • 16
    • 77951547489 scopus 로고    scopus 로고
    • Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging
    • Eitel I, Nowak M, Stehl C, et al. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging. Am Heart J. 2010;159:882-890.
    • (2010) Am Heart J , vol.159 , pp. 882-890
    • Eitel, I.1    Nowak, M.2    Stehl, C.3
  • 18
    • 48749130828 scopus 로고    scopus 로고
    • Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention
    • Niccoli G, Giubilato S, Russo E, et al. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. Eur Heart J. 2008;29:1843-1850.
    • (2008) Eur Heart J , vol.29 , pp. 1843-1850
    • Niccoli, G.1    Giubilato, S.2    Russo, E.3
  • 19
    • 0032776548 scopus 로고    scopus 로고
    • Reperfusion injury: Experimental evidence and clinical implications
    • DOI 10.1016/S0002-8703(99)70323-6
    • Ambrosio G, Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J. 1999;138(2 Pt 2):S69-S75. (Pubitemid 29379644)
    • (1999) American Heart Journal , vol.138 , Issue.2 II
    • Ambrosio, G.1    Tritto, I.2
  • 21
    • 84856491833 scopus 로고    scopus 로고
    • The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion
    • Raedschelders K, Ansley DM, Chen DD. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther. 2012;133:230-255.
    • (2012) Pharmacol Ther , vol.133 , pp. 230-255
    • Raedschelders, K.1    Ansley, D.M.2    Chen, D.D.3
  • 22
    • 77955285843 scopus 로고    scopus 로고
    • Molecular mechanisms underlying the activation of eNOS
    • Fleming I. Molecular mechanisms underlying the activation of eNOS. Pflugers Arch. 2010;459:793-806.
    • (2010) Pflugers Arch , vol.459 , pp. 793-806
    • Fleming, I.1
  • 23
    • 77950632502 scopus 로고    scopus 로고
    • Peroxynitrite induces destruction of the tetrahydrobiopterin and heme in endothelial nitric oxide synthase: Transition from reversible to irreversible enzyme inhibition
    • Chen W, Druhan LJ, Chen CA, et al. Peroxynitrite induces destruction of the tetrahydrobiopterin and heme in endothelial nitric oxide synthase: transition from reversible to irreversible enzyme inhibition. Biochemistry. 2010;49:3129-3137.
    • (2010) Biochemistry , vol.49 , pp. 3129-3137
    • Chen, W.1    Druhan, L.J.2    Chen, C.A.3
  • 24
    • 0032541980 scopus 로고    scopus 로고
    • Albumin microbubble persistence during myocardial contrast echocardiography is associated with microvascular endothelial glycocalyx damage
    • Lindner JR, Ismail S, Spotnitz WD, et al. Albumin microbubble persistence during myocardial contrast echocardiography is associated with microvascular endothelial glycocalyx damage. Circulation. 1998;98:2187-2194. (Pubitemid 28527479)
    • (1998) Circulation , vol.98 , Issue.20 , pp. 2187-2194
    • Lindner, J.R.1    Ismail, S.2    Spotnitz, W.D.3    Skyba, D.M.4    Jayaweera, A.R.5    Kaul, S.6
  • 25
    • 70449514842 scopus 로고    scopus 로고
    • Coronary microembolization: From bedside to bench and back to bedside
    • Heusch G, Kleinbongard P, Böse D, et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation. 2009;120:1822-1836.
    • (2009) Circulation , vol.120 , pp. 1822-1836
    • Heusch, G.1    Kleinbongard, P.2    Böse, D.3
  • 26
    • 79952673992 scopus 로고    scopus 로고
    • Composition of coronary thrombus in acute myocardial infarction
    • Silvain J, Collet JP, Nagaswami C, et al. Composition of coronary thrombus in acute myocardial infarction. J Am Coll Cardiol. 2011;57:1359-1367.
    • (2011) J Am Coll Cardiol , vol.57 , pp. 1359-1367
    • Silvain, J.1    Collet, J.P.2    Nagaswami, C.3
  • 28
    • 65249135889 scopus 로고    scopus 로고
    • Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction
    • Fokkema ML, Vlaar PJ, Svilaas T, et al. Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction. Eur Heart J. 2009;30:908-915.
    • (2009) Eur Heart J , vol.30 , pp. 908-915
    • Fokkema, M.L.1    Vlaar, P.J.2    Svilaas, T.3
  • 29
    • 0020579761 scopus 로고
    • Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog
    • Engler RL, Schmid-Schönbein GW, Pavelec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol. 1983;111:98-111. (Pubitemid 13117180)
    • (1983) American Journal of Pathology , vol.111 , Issue.1 , pp. 98-111
    • Engler, R.L.1    SchmidSchonbein, G.W.2    Pavelec, R.S.3
  • 30
    • 0033583132 scopus 로고    scopus 로고
    • Endothelial injuries of coronary arteries distal to thrombotic sites: Role of adhesive interaction between endothelial P-selectin and leukocyte sialyl Lewis(X)
    • Eguchi H, Ikeda H, Murohara T, et al. Endothelial injuries of coronary arteries distal to thrombotic sites: role of adhesive interaction between endothelial P-selectin and leukocyte sialyl LewisX. Circ Res. 1999;84:525-535. (Pubitemid 29138589)
    • (1999) Circulation Research , vol.84 , Issue.5 , pp. 525-535
    • Eguchi, H.1    Ikeda, H.2    Murohara, T.3    Yasukawa, H.4    Haramaki, N.5    Sakisaka, S.6    Imaizumi, T.7
  • 31
    • 77249090826 scopus 로고    scopus 로고
    • Myeloperoxidase may contribute to the no-reflow phenomenon in patients with acute myocardial infarction
    • Funayama H, Ishikawa SE, Sugawara Y, et al. Myeloperoxidase may contribute to the no-reflow phenomenon in patients with acute myocardial infarction. Int J Cardiol. 2010;139:187-192.
    • (2010) Int J Cardiol , vol.139 , pp. 187-192
    • Funayama, H.1    Ishikawa, S.E.2    Sugawara, Y.3
  • 32
    • 84864945934 scopus 로고    scopus 로고
    • Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention
    • Akpek M, Kaya MG, Lam YY, et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012;110:621-627.
    • (2012) Am J Cardiol , vol.110 , pp. 621-627
    • Akpek, M.1    Kaya, M.G.2    Lam, Y.Y.3
  • 33
    • 78349246710 scopus 로고    scopus 로고
    • The contribution of intramyocardial hemorrhage to the "noreflow phenomenon": A study performed by cardiac magnetic resonance
    • Marra MP, Cacciavillani L, Corbetti F, et al. The contribution of intramyocardial hemorrhage to the "noreflow phenomenon": a study performed by cardiac magnetic resonance. Echocardiography. 2010;27:1120-1129.
    • (2010) Echocardiography , vol.27 , pp. 1120-1129
    • Marra, M.P.1    Cacciavillani, L.2    Corbetti, F.3
  • 34
    • 84883295647 scopus 로고    scopus 로고
    • Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: Influence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction
    • Husser O, Monmeneu JV, Sanchis J, et al. Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: influence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction. Int J Cardiol. 2013;167:2047-2054.
    • (2013) Int J Cardiol , vol.167 , pp. 2047-2054
    • Husser, O.1    Monmeneu, J.V.2    Sanchis, J.3
  • 35
    • 73449105770 scopus 로고    scopus 로고
    • Intramyocardial hemorrhage and microvascular obstruction after primary percutaneous coronary intervention
    • Beek AM, Nijveldt R, van Rossum AC. Intramyocardial hemorrhage and microvascular obstruction after primary percutaneous coronary intervention. Int J Cardiovasc Imaging. 2010;26:49-55.
    • (2010) Int J Cardiovasc Imaging , vol.26 , pp. 49-55
    • Beek, A.M.1    Nijveldt, R.2    Van Rossum, A.C.3
  • 36
    • 38349190874 scopus 로고    scopus 로고
    • The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: Results of the multicenter AMICI study
    • AMICI Investigators
    • Galiuto L, Garramone B, Scarà A, et al AMICI Investigators. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study. J Am Coll Cardiol. 2008;51:552-559.
    • (2008) J Am Coll Cardiol , vol.51 , pp. 552-559
    • Galiuto, L.1    Garramone, B.2    Scarà, A.3
  • 39
    • 39749135567 scopus 로고    scopus 로고
    • 2 receptor stimulation on platelet activation-aggregation: Differences between canine and human models
    • DOI 10.1016/j.thromres.2007.07.002, PII S0049384807002630
    • Linden MD, Barnard MR, Frelinger AL, et al. Effect of adenosine A2 receptor stimulation on platelet activation-aggregation: differences between canine and human models. Thromb Res. 2008;121:689-698. (Pubitemid 351305291)
    • (2008) Thrombosis Research , vol.121 , Issue.5 , pp. 689-698
    • Linden, M.D.1    Barnard, M.R.2    Frelinger, A.L.3    Michelson, A.D.4    Przyklenk, K.5
  • 40
    • 0034625177 scopus 로고    scopus 로고
    • Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction
    • Marzilli M, Orsini E, Marraccini P, Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation. 2000;101:2154-2159. (Pubitemid 30253043)
    • (2000) Circulation , vol.101 , Issue.18 , pp. 2154-2159
    • Marzilli, M.1    Orsini, E.2    Marraccini, P.3    Testa, R.4
  • 41
    • 33748070798 scopus 로고    scopus 로고
    • Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes
    • DOI 10.1136/hrt.2005.075077
    • Vijayalakshmi K, Whittaker VJ, Kunadian B, et al. Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes. Heart. 2006;92:1278-1284. (Pubitemid 44298880)
    • (2006) Heart , vol.92 , Issue.9 , pp. 1278-1284
    • Vijayalakshmi, K.1    Whittaker, V.J.2    Kunadian, B.3    Graham, J.4    Wright, R.A.5    Hall, J.A.6    Sutton, A.7    De Belder, M.A.8
  • 43
    • 79953254581 scopus 로고    scopus 로고
    • New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention
    • Grygier M, Araszkiewicz A, Lesiak M, et al. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol. 2011;107:1131-1135.
    • (2011) Am J Cardiol , vol.107 , pp. 1131-1135
    • Grygier, M.1    Araszkiewicz, A.2    Lesiak, M.3
  • 44
    • 0033571512 scopus 로고    scopus 로고
    • Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: The Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial
    • Mahaffey KW, Puma JA, Barbagelata NA, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol. 1999;34:1711-1720.
    • (1999) J Am Coll Cardiol , vol.34 , pp. 1711-1720
    • Mahaffey, K.W.1    Puma, J.A.2    Barbagelata, N.A.3
  • 45
    • 27644525710 scopus 로고    scopus 로고
    • Improvement in microvascular reflow and reduction of infarct size with Adenosine in patients undergoing primary coronary stenting
    • DOI 10.1016/j.amjcard.2005.06.090, PII S0002914905013494
    • Micari A, Belcik TA, Balcells EA, et al. Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting. Am J Cardiol. 2005;96:1410-1415. (Pubitemid 41566624)
    • (2005) American Journal of Cardiology , vol.96 , Issue.10 , pp. 1410-1415
    • Micari, A.1    Belcik, T.A.2    Balcells, E.A.3    Powers, E.4    Wei, K.5    Kaul, S.6    Lindner, J.R.7
  • 46
    • 20344394410 scopus 로고    scopus 로고
    • A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II)
    • DOI 10.1016/j.jacc.2005.02.061, PII S073510970500536X
    • Ross AM, Gibbons RJ, Stone GW, et al AMISTAD-II Investigators. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol. 2005;45:1775-1780. (Pubitemid 40779856)
    • (2005) Journal of the American College of Cardiology , vol.45 , Issue.11 , pp. 1775-1780
    • Ross, A.M.1    Gibbons, R.J.2    Stone, G.W.3    Kloner, R.A.4    Alexander, R.W.5
  • 47
    • 33749485077 scopus 로고    scopus 로고
    • Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: The AMISTAD-2 trial
    • DOI 10.1093/eurheartj/ehl094
    • Kloner RA, Forman MB, Gibbons RJ, et al. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. Eur Heart J. 2006;27:2400-2405. (Pubitemid 44522145)
    • (2006) European Heart Journal , vol.27 , Issue.20 , pp. 2400-2405
    • Kloner, R.A.1    Forman, M.B.2    Gibbons, R.J.3    Ross, A.M.4    Alexander, R.W.5    Stone, G.W.6
  • 48
    • 84859812693 scopus 로고    scopus 로고
    • Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: A meta-analysis of randomized trials
    • Navarese EP, Buffon A, Andreotti F, et al. Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trials. Atherosclerosis. 2012;222:1-7.
    • (2012) Atherosclerosis , vol.222 , pp. 1-7
    • Navarese, E.P.1    Buffon, A.2    Andreotti, F.3
  • 50
    • 84855702522 scopus 로고    scopus 로고
    • Microvascular responsiveness in obesity: Implications for therapeutic intervention
    • Bagi Z, Feher A, Cassuto J. Microvascular responsiveness in obesity: implications for therapeutic intervention. Br J Pharmacol. 2012;165:544-560.
    • (2012) Br J Pharmacol , vol.165 , pp. 544-560
    • Bagi, Z.1    Feher, A.2    Cassuto, J.3
  • 51
    • 0017408741 scopus 로고
    • Sodium nitroprusside as a coronary vasodilator in man. I. Effect of intracoronary sodium nitroprusside on coronary arteries, angina pectoris, and coronary blood flow
    • Yeh BK, Gosselin AJ, Swaye PS, et al. Sodium nitroprusside as a coronary vasodilator in man. I. Effect of intracoronary sodium nitroprusside on coronary arteries, angina pectoris, and coronary blood flow. Am Heart J. 1977;93:610-616. (Pubitemid 8095570)
    • (1977) American Heart Journal , vol.93 , Issue.5 , pp. 610-616
    • Yeh, B.K.1    Gosselin, A.J.2    Swaye, P.S.3
  • 52
    • 34648830908 scopus 로고    scopus 로고
    • Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute myocardial infarction
    • DOI 10.1536/ihj.48.423
    • Shinozaki N, Ichinose H, Yahikozawa K, et al. Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute myocardial infarction. Int Heart J. 2007;48:423-433. (Pubitemid 47455793)
    • (2007) International Heart Journal , vol.48 , Issue.4 , pp. 423-433
    • Shinozaki, N.1    Ichinose, H.2    Yahikozawa, K.3    Shimada, H.4    Hoshino, K.5
  • 53
    • 33750343046 scopus 로고    scopus 로고
    • Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial
    • Amit G, Cafri C, Yaroslavtsev S, et al. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial. Am Heart J. 2006;152:887.e9-e14.
    • (2006) Am Heart J , vol.152
    • Amit, G.1    Cafri, C.2    Yaroslavtsev, S.3
  • 55
    • 65649142906 scopus 로고    scopus 로고
    • Nicorandil treatment in patients with acute myocardial infarction: A meta-analysis
    • Iwakura K, Ito H, Okamura A, et al. Nicorandil treatment in patients with acute myocardial infarction: a meta-analysis. Circ J. 2009;73:925-931.
    • (2009) Circ J , vol.73 , pp. 925-931
    • Iwakura, K.1    Ito, H.2    Okamura, A.3
  • 56
    • 43949086866 scopus 로고    scopus 로고
    • Circulating endothelial cell count, plasma vWF and soluble ICAM-1 levels following primary or elective percutaneous coronary intervention
    • DOI 10.1016/j.atherosclerosis.2007.09.005, PII S002191500700545X
    • Vargová K, Toth-Zsamboki E, Beres BJ, et al. Circulating endothelial cell count, plasma vWF and soluble ICAM-1 levels following primary or elective percutaneous coronary intervention. Atherosclerosis. 2008;198:366-372. (Pubitemid 351707379)
    • (2008) Atherosclerosis , vol.198 , Issue.2 , pp. 366-372
    • Vargova, K.1    Toth-Zsamboki, E.2    Beres, B.J.3    Bencze, J.4    Kerecsen, G.5    Gulacsi-Bardos, P.6    Kiss, R.G.7    Preda, I.8
  • 57
    • 0025542037 scopus 로고
    • Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat
    • Tsao PS, Aoki N, Lefer DJ, et al. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 1990;82:1402-1412.
    • (1990) Circulation , vol.82 , pp. 1402-1412
    • Tsao, P.S.1    Aoki, N.2    Lefer, D.J.3
  • 59
    • 0026542028 scopus 로고
    • Xanthine oxidase: Its role in the no-reflow phenomenon
    • Punch J, Rees R, Cashmer B, et al. Xanthine oxidase: its role in the no-reflow phenomenon. Surgery. 1992;111:169-176.
    • (1992) Surgery , vol.111 , pp. 169-176
    • Punch, J.1    Rees, R.2    Cashmer, B.3
  • 60
    • 0028939857 scopus 로고
    • Nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester decreases ischemic damage in reversible focal cerebral ischemia in hyperglycemic rats
    • Quast MJ, Wei J, Huang NC. Nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester decreases ischemic damage in reversible focal cerebral ischemia in hyperglycemic rats. Brain Res. 1995;677:204-212.
    • (1995) Brain Res , vol.677 , pp. 204-212
    • Quast, M.J.1    Wei, J.2    Huang, N.C.3
  • 61
    • 77952236126 scopus 로고    scopus 로고
    • Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury
    • Ong SB, Subrayan S, Lim SY, et al. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation. 2010;121:2012-2022.
    • (2010) Circulation , vol.121 , pp. 2012-2022
    • Ong, S.B.1    Subrayan, S.2    Lim, S.Y.3
  • 62
    • 0035171760 scopus 로고    scopus 로고
    • N-acetylcysteine improves coronary and peripheral vascular function
    • DOI 10.1016/S0735-1097(00)01093-7, PII S0735109700010937
    • Andrews NP, Prasad A, Quyyumi AA. N-acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol. 2001;37:117-123. (Pubitemid 32051726)
    • (2001) Journal of the American College of Cardiology , vol.37 , Issue.1 , pp. 117-123
    • Andrews, N.P.1    Prasad, A.2    Quyyumi, A.A.3
  • 63
    • 84869090904 scopus 로고    scopus 로고
    • Effects of allopurinol on coronary microvascular and left ventricular function in patients with idiopathic dilated cardiomyopathy
    • Erdogan D, Tayyar S, Uysal BA, et al. Effects of allopurinol on coronary microvascular and left ventricular function in patients with idiopathic dilated cardiomyopathy. Can J Cardiol. 2012;28:721-727.
    • (2012) Can J Cardiol , vol.28 , pp. 721-727
    • Erdogan, D.1    Tayyar, S.2    Uysal, B.A.3
  • 64
    • 66949134905 scopus 로고    scopus 로고
    • Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: Implications for reactive oxygen species
    • Bagi Z, Feher A, Beleznai T. Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: implications for reactive oxygen species. Pharmacol Rep. 2009;61:99-104.
    • (2009) Pharmacol Rep , vol.61 , pp. 99-104
    • Bagi, Z.1    Feher, A.2    Beleznai, T.3
  • 66
    • 77951667406 scopus 로고    scopus 로고
    • Relationship between hyperglycemia and coronary vascular resistance in non-diabetic patients
    • Ichiki H, Hamasaki S, Nakasaki M, et al. Relationship between hyperglycemia and coronary vascular resistance in non-diabetic patients. Int J Cardiol. 2010;141:44-48.
    • (2010) Int J Cardiol , vol.141 , pp. 44-48
    • Ichiki, H.1    Hamasaki, S.2    Nakasaki, M.3
  • 67
    • 79955075627 scopus 로고    scopus 로고
    • Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes
    • Beleznai T, Feher A, Spielvogel D, et al. Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes. Am J Physiol Heart Circ Physiol. 2011;300:H777-H783.
    • (2011) Am J Physiol Heart Circ Physiol , vol.300
    • Beleznai, T.1    Feher, A.2    Spielvogel, D.3
  • 69
    • 78650863986 scopus 로고    scopus 로고
    • Impact of chronic pre-treatment of statins on the level of systemic inflammation and myocardial perfusion in patients undergoing primary angioplasty
    • Oduncu V, Tanalp AC, Erkol A, et al. Impact of chronic pre-treatment of statins on the level of systemic inflammation and myocardial perfusion in patients undergoing primary angioplasty. Am J Cardiol. 2011;107:179-185.
    • (2011) Am J Cardiol , vol.107 , pp. 179-185
    • Oduncu, V.1    Tanalp, A.C.2    Erkol, A.3
  • 70
    • 77949337131 scopus 로고    scopus 로고
    • Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: The STATIN STEMI trial
    • Kim JS, Kim J, Choi D, et al. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. JACC Cardiovasc Interv. 2010;3:332-339.
    • (2010) JACC Cardiovasc Interv , vol.3 , pp. 332-339
    • Kim, J.S.1    Kim, J.2    Choi, D.3
  • 72
    • 70349464019 scopus 로고    scopus 로고
    • Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: An individual patient-data pooled analysis of 11 trials
    • Burzotta F, De Vita M, Gu YL, et al. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J. 2009;30:2193-2203.
    • (2009) Eur Heart J , vol.30 , pp. 2193-2203
    • Burzotta, F.1    De Vita, M.2    Gu, Y.L.3
  • 75
    • 76849109547 scopus 로고    scopus 로고
    • Increased rate of stent thrombosis and target lesion revascularization after filter protection in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: 15-Month follow-up of the DEDICATION (Drug Elution and Distal Protection in ST Elevation Myocardial Infarction) trial
    • Kaltoft A, Kelbaek H, Kløvgaard L, et al. Increased rate of stent thrombosis and target lesion revascularization after filter protection in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: 15-month follow-up of the DEDICATION (Drug Elution and Distal Protection in ST Elevation Myocardial Infarction) trial. J Am Coll Cardiol. 2010;55:867-871.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 867-871
    • Kaltoft, A.1    Kelbaek, H.2    Kløvgaard, L.3
  • 76
    • 58049219011 scopus 로고    scopus 로고
    • Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: A comprehensive meta-analysis of randomized trials
    • Bavry AA, Kumbhani DJ, Bhatt DL. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eur Heart J. 2008;29:2989-3001.
    • (2008) Eur Heart J , vol.29 , pp. 2989-3001
    • Bavry, A.A.1    Kumbhani, D.J.2    Bhatt, D.L.3
  • 77
    • 0032534461 scopus 로고    scopus 로고
    • Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary- artery stents in acute myocardial infarction
    • Neumann FJ, Blasini R, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation. 1998;98:2695-2701. (Pubitemid 28564004)
    • (1998) Circulation , vol.98 , Issue.24 , pp. 2695-2701
    • Neumann, F.-J.1    Blasini, R.2    Schmitt, C.3    Alt, E.4    Dirschinger, J.5    Gawaz, M.6    Kastrati, A.7    Schomig, A.8
  • 79
    • 84857624987 scopus 로고    scopus 로고
    • Meta-analysis of prospective randomized controlled trials comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
    • Shimada YJ, Nakra NC, Fox JT, Kanei Y. Meta-analysis of prospective randomized controlled trials comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2012;109:624-628.
    • (2012) Am J Cardiol , vol.109 , pp. 624-628
    • Shimada, Y.J.1    Nakra, N.C.2    Fox, J.T.3    Kanei, Y.4
  • 80
    • 84858072051 scopus 로고    scopus 로고
    • Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: A randomised trial
    • Thiele H, Wöhrle J, Hambrecht R, et al. Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. Lancet. 2012;379:923-931.
    • (2012) Lancet , vol.379 , pp. 923-931
    • Thiele, H.1    Wöhrle, J.2    Hambrecht, R.3
  • 81
    • 77958577331 scopus 로고    scopus 로고
    • Comparison of 600 versus 300-mg clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty
    • Mangiacapra F, Muller O, Ntalianis A, et al. Comparison of 600 versus 300-mg clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol. 2011;106:1208-1211.
    • (2011) Am J Cardiol , vol.106 , pp. 1208-1211
    • Mangiacapra, F.1    Muller, O.2    Ntalianis, A.3
  • 82
    • 84863360689 scopus 로고    scopus 로고
    • A high loading dose of clopidogrel reduces myocardial infarct size in patients undergoing primary percutaneous coronary intervention: A magnetic resonance imaging study
    • Song YB, Hahn JY, Gwon HC, et al. A high loading dose of clopidogrel reduces myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging study. Am Heart J. 2012;163:500-507.
    • (2012) Am Heart J , vol.163 , pp. 500-507
    • Song, Y.B.1    Hahn, J.Y.2    Gwon, H.C.3
  • 83
    • 33751171952 scopus 로고    scopus 로고
    • High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: Role of xanthine oxidase-derived superoxide anion
    • Erdei N, Tóth A, Pásztor ET, et al. High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion. Am J Physiol Heart Circ Physiol. 2006;291:H2107-H2115.
    • (2006) Am J Physiol Heart Circ Physiol , vol.291
    • Erdei, N.1    Tóth, A.2    Pásztor, E.T.3
  • 84
    • 0033774380 scopus 로고    scopus 로고
    • Renin-angiotensin system blockade improves endothelial dysfunction in hypertension
    • Goto K, Fujii K, Onaka U, et al. Renin-angiotensin system blockade improves endothelial dysfunction in hypertension. Hypertension. 2000;36:575-580.
    • (2000) Hypertension , vol.36 , pp. 575-580
    • Goto, K.1    Fujii, K.2    Onaka, U.3
  • 85
    • 0028327659 scopus 로고
    • Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: Interaction at the receptor level
    • Hecker M, Pörsti I, Bara AT, Busse R. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level. Br J Pharmacol. 1994;111:238-244. (Pubitemid 24148732)
    • (1994) British Journal of Pharmacology , vol.111 , Issue.1 , pp. 238-244
    • Hecker, M.1    Porsti, I.2    Bara, A.T.3    Busse, R.4
  • 86
    • 77957289366 scopus 로고    scopus 로고
    • Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis
    • Reriani M, Raichlin E, Prasad A, et al. Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation. 2010;122:958-966.
    • (2010) Circulation , vol.122 , pp. 958-966
    • Reriani, M.1    Raichlin, E.2    Prasad, A.3
  • 87
    • 84855831251 scopus 로고    scopus 로고
    • Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial)
    • De Luca G, Iorio S, Venegoni L, Marino P. Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial). Am J Cardiol. 2012;109:202-207.
    • (2012) Am J Cardiol , vol.109 , pp. 202-207
    • De Luca, G.1    Iorio, S.2    Venegoni, L.3    Marino, P.4
  • 88
    • 27144440323 scopus 로고    scopus 로고
    • Early administration of intracoronary verapamil improves myocardial perfusion during percutaneous coronary interventions for acute myocardial infarction
    • Hang CL, Wang CP, Yip HK, et al. Early administration of intracoronary verapamil improves myocardial perfusion during percutaneous coronary interventions for acute myocardial infarction. Chest. 2005;128:2593-2598.
    • (2005) Chest , vol.128 , pp. 2593-2598
    • Hang, C.L.1    Wang, C.P.2    Yip, H.K.3
  • 89
    • 0036072757 scopus 로고    scopus 로고
    • Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: Results of the randomized, controlled vasodilator prevention of no-reflow (VAPOR) trial
    • Michaels AD, Appleby M, Otten MH, et al. Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. J Invasive Cardiol. 2002;14:299-302. (Pubitemid 34651235)
    • (2002) Journal of Invasive Cardiology , vol.14 , Issue.6 , pp. 299-302
    • Michaels, A.D.1    Appleby, M.2    Otten, M.H.3    Dauterman, K.4    Ports, T.A.5    Chou, T.M.6    Gibson, C.M.7
  • 90
    • 0033101517 scopus 로고    scopus 로고
    • Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction
    • Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol. 1999;33:654-660.
    • (1999) J Am Coll Cardiol , vol.33 , pp. 654-660
    • Ito, H.1    Taniyama, Y.2    Iwakura, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.